Table of contents

Therapeutics

• Review: varicella vaccination is effective in children (1 January, 2002)
• Oseltamivir was safe and effective for prophylaxis of influenza in the frail elderly (1 January, 2002)
• Review: placebo is better than no treatment for subjective continuous outcomes and for treatment of pain (1 January, 2002)
• Omalizumab reduced inhaled corticosteroid use and exacerbations in childhood allergic asthma (1 January, 2002)
• Review: angiotensin-converting enzyme inhibitors reduce the progression of non-diabetic renal disease (1 January, 2002)
• Predischarge coronary angiography was better than exercise testing for reducing hospital use after low-risk chest pain (1 January, 2002)
• Carvedilol reduced mortality and morbidity caused by myocardial infarction in patients with left ventricular dysfunction (1 January, 2002)
• Long term and short term oral anticoagulation treatments were equivalent for venous thromboembolism (1 January, 2002)
• 3 months and 1 year of oral anticoagulant treatment were equivalent for idiopathic proximal deep venous thrombosis (1 January, 2002)
• Home monitoring service was more effective than usual care in patients with essential hypertension (1 January, 2002)
• Review: antibiotics modestly increase remission rates in acute bacterial conjunctivitis (1 January, 2002)
• Dietary fibre supplementation with psyllium or gum arabic reduced faecal incontinence in community-living adults (1 January, 2002)
• 17β-estradiol reduced depressive and somatic symptoms in perimenopausal women (1 January, 2002)
• Brief psychodynamic interpersonal treatment after deliberate self poisoning reduced suicidal ideation and deliberate self harm (1 January, 2002)
• Support by another mother and a child-life specialist decreased anxiety in mothers of children with chronic illnesses (1 January, 2002)
• Review: cannabinoids and codeine have similar effects on pain relief, but cannabinoids commonly cause psychotropic adverse effects (1 January, 2002)
• Review: cannabinoids control chemotherapy-induced nausea and vomiting but increase the risk of side effects (1 January, 2002)
• Surgery relieved symptoms but decreased survival more than medical treatment in gastro-oesophageal reflux disease (1 January, 2002)